Tscan Therapeutics shares owned by Standard Life Aberdeen
Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Standard Life Aberdeen
from 13F filings
Historical chart of Standard Life Aberdeen investment in Tscan Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Tscan Therapeutics held by Standard Life Aberdeen consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Tscan Therapeutics by Standard Life Aberdeen
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $1.6M | 200k | 7.94 |
2023-12-31 | $1.2M | 200k | 5.83 |